You are here: Home » News-CM » Companies » News
Business Standard

Board of GlaxoSmithkline Consumer Healthcare approves scheme of amalgamation

Capital Market 

At held on 03 December 2018

The Board of at its held on 03 December 2018 approved a scheme of amalgamation between the Company and ('HUL'), and their respective shareholders and creditors ('Scheme') under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013.

The Scheme is subject to necessary statutory and regulatory approvals under applicable laws, including by and National Stock Exchange of India Limited, SEBI, Competition Commission of India, the National Company Law Tribunal, and the respective shareholders and creditors of the Company and HUL.

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, December 03 2018. 14:59 IST